Case Western Reserve, Lucid Diagnostics sign agreement on Barrett's Esophagus detector

(University Hospitals Cleveland Medical Center) Case Western Reserve University and Lucid Diagnostics, a subsidiary of publicly traded New York-based medical device company, PAVmed Inc. (Nasdaq: PAVM), have signed an exclusive license agreement to commercialize a technology that quickly and accurately detects Barrett's Esophagus. University Hospitals physicians will implement the technology.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news